phenylbutazone and alprenolol

phenylbutazone has been researched along with alprenolol in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19905 (55.56)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrews, PR; Craik, DJ; Martin, JL1
Lüllmann, H; Timmermans, PB; Weikert, GM; Ziegler, A1
Topliss, JG; Yoshida, F1
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL1
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P1
Gozalbes, R; Pineda-Lucena, A1
Brodin, A1
Agren, A; Brodin, A1
Brodin, A; Nilsson, MI1

Other Studies

9 other study(ies) available for phenylbutazone and alprenolol

ArticleYear
Functional group contributions to drug-receptor interactions.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:12

    Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship

1984
Accumulation of drugs by guinea pig isolated atria. Quantitative correlations.
    Journal of medicinal chemistry, 1980, Volume: 23, Issue:5

    Topics: Animals; Chemistry, Pharmaceutical; Electric Stimulation; Guinea Pigs; Humans; In Vitro Techniques; Kinetics; Myocardium; Pharmaceutical Preparations; Protein Binding; Serum Albumin; Solubility; Time Factors

1980
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Cheminformatic models to predict binding affinities to human serum albumin.
    Journal of medicinal chemistry, 2001, Dec-06, Volume: 44, Issue:25

    Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids

2001
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
    Journal of medicinal chemistry, 2004, Mar-25, Volume: 47, Issue:7

    Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties

2004
QSAR-based solubility model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2010, Oct-01, Volume: 18, Issue:19

    Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water

2010
Rates of transfer of organic protolytic solutes between an aqueous and an organic phase. IV. Mass transfer in the presence of surfactants.
    Acta pharmaceutica Suecica, 1975, Volume: 12, Issue:1

    Topics: Alprenolol; Chemical Phenomena; Chemistry; Chlorpromazine; Cyclohexanes; Ephedrine; Hydrogen-Ion Concentration; Phenylbutazone; Solutions; Surface-Active Agents; Water

1975
Rates of transfer of organic protolytic solutes between an aqueous and an organic phase. I. A study of the transfer dependency of pH and the absolute rate of resolvation.
    Acta pharmaceutica Suecica, 1971, Volume: 8, Issue:6

    Topics: Alprenolol; Cyclohexanes; Ephedrine; Hydrogen-Ion Concentration; Kinetics; Nortriptyline; Phenothiazines; Phenylbutazone; Procaine; Promazine; Solubility; Spectrophotometry; Water

1971
Rates of transfer of organic protolytic solutes between an aqueous and an organic phase. II. Rates of mass transfer between water and different organic liquids.
    Acta pharmaceutica Suecica, 1973, Volume: 10, Issue:3

    Topics: Alprenolol; Benzene; Chloroform; Cyclohexanes; Ephedrine; Hydrogen-Ion Concentration; Methods; Nortriptyline; Pentobarbital; Phenobarbital; Phenylbutazone; Promazine; Solubility; Solvents; Water

1973